The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition ...

We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...

In this piece, we will look at the stocks that Jim Cramer recently discussed.

This year’s JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...

In the wake of UnitedHealth CEO's sidewalk assassination, professional gatherings are boosting security and safety oversight for attendees.

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Highlights from the third day included information about Quanterix's new Simoa One platform, expected to launch at the end of ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...